BioStem Technologies, Inc. (BSEM)
Nasdaq: BSEM · CIK 0001658678 · United States
Every official BioStem Technologies, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open BSEM filings
BioStem Technologies, Inc. documents
- BioStem Technologies, Inc. 10-K 2026BSEM 10-K 2026: annual report for fiscal 2026
- BioStem Technologies, Inc. 10-K 2025BSEM 10-K 2025: annual report for fiscal 2025
- BioStem Technologies, Inc. 10-K 2024BSEM 10-K 2024: annual report for fiscal 2024
- BioStem Technologies, Inc. 10-K 2023BSEM 10-K 2023: annual report for fiscal 2023
- BioStem Technologies, Inc. 10-K 2022BSEM 10-K 2022: annual report for fiscal 2022
- BioStem Technologies, Inc. 10-Q 2026BSEM 10-Q 2026: quarterly report for fiscal 2026
- BioStem Technologies, Inc. 10-Q 2025BSEM 10-Q 2025: quarterly report for fiscal 2025
- BioStem Technologies, Inc. 10-Q 2024BSEM 10-Q 2024: quarterly report for fiscal 2024
- BioStem Technologies, Inc. 10-Q 2023BSEM 10-Q 2023: quarterly report for fiscal 2023
- BioStem Technologies, Inc. 10-Q 2022BSEM 10-Q 2022: quarterly report for fiscal 2022
- BioStem Technologies, Inc. 8-K 2026BSEM 8-K 2026: current report for fiscal 2026
- BioStem Technologies, Inc. 8-K 2025BSEM 8-K 2025: current report for fiscal 2025
- BioStem Technologies, Inc. 8-K 2024BSEM 8-K 2024: current report for fiscal 2024
- BioStem Technologies, Inc. 8-K 2023BSEM 8-K 2023: current report for fiscal 2023
- BioStem Technologies, Inc. 8-K 2022BSEM 8-K 2022: current report for fiscal 2022
- BioStem Technologies, Inc. DEF 14A 2026BSEM DEF 14A 2026: proxy statement for fiscal 2026
- BioStem Technologies, Inc. DEF 14A 2025BSEM DEF 14A 2025: proxy statement for fiscal 2025
- BioStem Technologies, Inc. DEF 14A 2024BSEM DEF 14A 2024: proxy statement for fiscal 2024
- BioStem Technologies, Inc. DEF 14A 2023BSEM DEF 14A 2023: proxy statement for fiscal 2023
- BioStem Technologies, Inc. DEF 14A 2022BSEM DEF 14A 2022: proxy statement for fiscal 2022
- BioStem Technologies, Inc. Form 4 2026BSEM Form 4 2026: insider trading filing for fiscal 2026
- BioStem Technologies, Inc. Form 4 2025BSEM Form 4 2025: insider trading filing for fiscal 2025
- BioStem Technologies, Inc. Form 4 2024BSEM Form 4 2024: insider trading filing for fiscal 2024
- BioStem Technologies, Inc. Form 4 2023BSEM Form 4 2023: insider trading filing for fiscal 2023
- BioStem Technologies, Inc. Form 4 2022BSEM Form 4 2022: insider trading filing for fiscal 2022
- BioStem Technologies, Inc. S-1 2026BSEM S-1 2026: registration statement for fiscal 2026
- BioStem Technologies, Inc. S-1 2025BSEM S-1 2025: registration statement for fiscal 2025
- BioStem Technologies, Inc. S-1 2024BSEM S-1 2024: registration statement for fiscal 2024
- BioStem Technologies, Inc. S-1 2023BSEM S-1 2023: registration statement for fiscal 2023
- BioStem Technologies, Inc. S-1 2022BSEM S-1 2022: registration statement for fiscal 2022
- BioStem Technologies, Inc. 13F 2026BSEM 13F 2026: institutional holdings for fiscal 2026
- BioStem Technologies, Inc. 13F 2025BSEM 13F 2025: institutional holdings for fiscal 2025
- BioStem Technologies, Inc. 13F 2024BSEM 13F 2024: institutional holdings for fiscal 2024
- BioStem Technologies, Inc. 13F 2023BSEM 13F 2023: institutional holdings for fiscal 2023
- BioStem Technologies, Inc. 13F 2022BSEM 13F 2022: institutional holdings for fiscal 2022
More companies